Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Validated stability studies for 40 paediatric extemporaneously compounded oral solutions and suspensions (Suspendit): acetazolamide, amphotericin b, atenolol, baclofen, budesonide, buspirone, captopril, clonazepam, dipyridamole, fluconazole, fluoxetine, g

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HPS-015
  • By: CARVALHO, Maria (Professional Compounding Centers of America, United States)
  • Co-author(s): Dr Maria Carvalho, Manager of PCCA Science (Professional Compounding Centers of America, Houston, United States)
    Mrs Melissa Merrell Rhoads, Formulations (Professional Compounding Centers of America, Houston, United States)
    Mrs Courtaney Davis, Formulations (Professional Compounding Centers of America, Houston, United States)
    Mrs Kendice Ip, Research and Development (Professional Compounding Centers of America, Houston, United States)
    Mr August S. Bassani, Formulations, Research and Development (Professional Compounding Centers of America, Houston, United States)
    Mr A.J. Day, Clinical Services (Professional Compounding Centers of America, Houston, United States)
    Mr Daniel Banov, Research and Development (Professional Compounding Centers of America, Houston, United States)
  • Abstract:

    Background: The pharmacological treatment of children is often challenging because most of the commercial medications are solid dosage forms (tablets and capsules) indicated for adults. There is a general lack of age-appropriate formulations, and the extemporaneous preparation of compounded oral liquids represents a key therapeutic alternative for ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses